Elsie Biotechnologies

Elsie BioTechnologies is a privately held biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapies by integrating discovery, development, and delivery approaches to enhance potency, reduce toxicity, and optimize delivery. Elsie's discovery platform accesses the entire oligonucleotide chemical space to refine current models of gene silencing and splicing modulation and applies proprietary P(V) chemistry technology to develop novel, diverse oligonucleotide therapies designed to be more effective, safer, and easier to deliver to target tissues.